AI assistant
Sending…
GENTEX CORP — Director's Dealing 2010
Dec 13, 2010
30893_dirs_2010-12-13_f442835c-4229-4951-90d1-2adb28fefae9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2010-12-10
Reporting Person: LANTING ARLYN J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-12-10 | Common Stock | M | 10000 | $13.705 | Acquired | 10000 | Direct |
| 2010-12-10 | Common Stock | M | 12000 | $15.945 | Acquired | 22000 | Direct |
| 2010-12-10 | Common Stock | M | 12000 | $15.925 | Acquired | 34000 | Direct |
| 2010-12-10 | Common Stock | M | 12000 | $18.035 | Acquired | 46000 | Direct |
| 2010-12-10 | Common Stock | S | 46000 | $28.7593 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-12-10 | Non-Employee Director Stock Option Grant | $13.705 | M | 10000 | Disposed | 2011-05-16 | Common Stock (10000) | Direct |
| 2010-12-10 | Non-Employee Director Stock Option Grant | $15.945 | M | 12000 | Disposed | 2012-05-09 | Common Stock (12000) | Direct |
| 2010-12-10 | Non-Employee Director Stock Option Grant | $15.925 | M | 12000 | Disposed | 2013-05-14 | Common Stock (12000) | Direct |
| 2010-12-10 | Non-Employee Director Stock Option Grant | $18.035 | M | 12000 | Disposed | 2014-05-13 | Common Stock (12000) | Direct |
Footnotes
F1: 313,250 Shares held indirectly by the "Arlyn J. Lanting Trust"
More from GENTEX CORP
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19